Lipid control of nutrient signaling
The study of phosphoinositides, or PIs, has been in vogue for some time, as this minor class of short-lived membrane phospholipids regulates many of a eukaryotic cell’s physiological functions, including cell polarity, cytoskeletal dynamics, and membrane traffic and signaling. Recent data reveal a mechanism based on local PI generation that couples cell signaling to cellular nutrient status (1).
![](http://www.asbmb.org/imagearchive/75776/PI.jpg)
Different PIs display distinct subcellular distributions, with PI 3-phosphates such as phosphatidylinositol 3-phosphate, or PI(3)P, and phosphatidylinositol 3,5-bisphosph ate, or PI(3,5)P2, being found predominantly within early and late endosomes or lysosomes. The lysosome, via the mechanistic target of rapamycin complex 1, or mTORC1, acts as a central metabolic control hub that integrates extracellular growth factor signals with the cellular nutrient and energy status to direct the cell into either an anabolic or a catabolic state (2,3).
Disruptions in mTORC1-mediated lysosomal signaling are implicated in diseases such as diabetes, cancer and neurodegeneration. Lysosomal mTORC1 activity depends on growth factor signals that trigger the class I-PI3K-mediated synthesis of plasma membrane PI(3,4,5)P3, which stimulates mTORC1 via its effector Akt (2,3).
Researchers now have uncovered control mechanisms elicited by local PI signals at late endosomes/lysosomes that integrate lysosomal mTORC1 activity with cellular nutrient status. Growth-factor deprivation causes the late endosomal/lysosomal recruitment of class II PI3Kbeta, which locally produces a late endosomal/lysosomal pool of phosphatidylinositol 3,4-bisphosphate, or PI(3,4)P2, that suppresses mTORC1 activity (1). How exactly such suppression occurs is only partly understood, but one important element appears to be the recruitment of inhibitory 14-3-3 proteins to the mTORC1 subunit Raptor by local PI(3,4)P2 (1).
These findings are surprising given the established function of plasma membrane PI(3,4)P2 synthesized downstream of class I-PI3Ks in the activation of mTORC1 via Akt in growth factor-activated cells. These findings suggest a model whereby local PI switches at late endosomes/lysosomes sense and control cellular nutrient status to regulate mTORC1 activity (1). Consistent with this, late endosomal PI(3)P (4) and PI(3,5)P2 have been shown to activate mTORC1 locally — for example, by association of PI(3,5)P2 with the Raptor subunit of mTORC1(5) — under conditions of ample growth factor and nutrient supply.
As always in a fast-moving field, many open questions remain. For example, recent studies have revealed a surprising, though mechanistically poorly understood, link between lysosome position and nutrient signaling via mTORC1. Peripheral lysosomes display elevated mTORC1 activity compared with perinuclear lysosomes (6). How local pools of PI(3)P or PI(3,4)P2 couple lysosome position to the activity status of mTORC1 is essentially unknown. One possibility is that some of the factors that control lysosome position and/or mTORC1 signaling are regulated by the local PI content. PIs also may modulate the association of mTORC1 components with the lysosomal transport machinery. For example, PIs might regulate the recently described interaction between the Arl8-activating BLOC1-related complex and the mTORC1-associated Ragulator/LAMTOR complex (7).
Interestingly, PI(3)P synthesis by the class III PI3K Vps34 has been shown to facilitate the recruitment of the kinesin-1 adaptor FYCO1 to late endosomes/lysosomes (4). How the resulting dispersion of late endosomes/lysosomes to the cell periphery then causes elevated mTORC1 signaling is unclear. As lysosomes contain a variety of other PI lipids, including PI(4)P and PI(4,5)P2, further unanswered questions are whether and how these lipid pools may be subject to nutrient regulation or, conversely, contribute to the coupling of lysosome function and position to nutrient signals.
We thus face exciting times for lipid biochemistry, as lipids have taken center stage in many aspects of cell physiology. Understanding how local lipid signals sense and control cellular nutrient status at distinct subcellular locations will remain an important area for future studies.
References
1. Marat, A.L., et al., Science 356, 968 (2017).
2. Hardie, D.G., Cell. Metab. 20, 939 (2014).
3. Zhang, C.S., et al., Cell. Metab. 20, 526 (2014).
4. Hong, Z., et al., J. Cell Biol. (2017).
5. Bridges, D., et al., Mol. Biol. Cell 23, 2955 (2012).
6. Korolchuk, V.I., et al., Nat. Cell Biol. 13, 453 (2011).
7. Pu, J., Keren-Kaplan, T., and Bonifacino, J.S., J. Cell Biol. (2017).
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
![From the JBC archives: Madness, indoles and mercury-based cathartics](/getattachment/e26ef62e-685d-450f-b5e4-113430cfb888/JBC-archives-02-11-25-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
From the JBC archives: Madness, indoles and mercury-based cathartics
A 1907 paper sought to resolve an ongoing question of whether indole, a bacterial molecule in the gut, could cause insanity if overproduced.
![From the journals: JBC](/getattachment/05f125e8-aa95-4a9e-bd9c-896b3f72923c/FTJ-JBC-02-07-25-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
From the journals: JBC
Linking modified cysteines to cell migration. Recognizing protein tags for degradation. Disrupting C. difficile toxin production. Read about recent JBC papers on these topics.
![Becoming a scientific honey bee](/getattachment/7cb3cada-2249-4121-a9f5-63aa5bd6f213/Becoming-scientific-honey-bee-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Becoming a scientific honey bee
At the World Science Forum, a speaker’s call for scientists to go out and “make honey” felt like the answer to a question Katy Brewer had been considering for a long time.
![Mutant RNA exosome protein linked to neurodevelopmental defects](/getattachment/dbfd7c8c-5104-4903-8e97-2c82f9d97262/Mutant-RNA-exosome-protein-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Mutant RNA exosome protein linked to neurodevelopmental defects
Researchers at Emory University find that a missense mutation impairs RNA exosome assembly and translation and causes neurological disease.
![Study sheds light on treatment for rare genetic disorder](/getattachment/0f757086-65aa-452a-a87e-e2f381aee087/Treatment-for-rare-genitic-disorder-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Study sheds light on treatment for rare genetic disorder
Aaron Hoskins’ lab partnered with a drug company to understand how RNA-targeting drugs work on spinal muscular atrophy, a disorder resulting from errors in production of a protein related to muscle movement.
![Examining mechanisms of protein complex at a basic cell biological level](/getattachment/f09ff397-048a-494d-9eea-d4b5eae8938d/Munson-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Examining mechanisms of protein complex at a basic cell biological level
Mary Munson is co-corresponding author on a study revealing functions and mechanisms of the exocyst that are essential to how molecules move across a membrane through vesicles in a cell.